Kevin Raymond Merrill Smith bought $100k of INGN
CEO and President at Inogen Inc. 11,709 shares at an average of $8.56, traded Mar 3, 2025, filed Mar 4, 2025.
Score components
- +25RoleCEO
- +10Trade size$100k at market
- +3Relative to holdingsHoldings up 20%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -1510b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-032638, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 1, 2025 | AGrant or award Common Stock10b5-1 | +1,500 | $8.33 | $12k | 16,054 | Mar 4, 2025 |
| Mar 1, 2025 | MOption exercise Common Stock10b5-1 | +28,333 | $0.00 | $0 | 44,387 | Mar 4, 2025 |
| Mar 1, 2025 | FTax withholding Common Stock10b5-1 | -13,700 | $8.33 | $114k | 30,687 | Mar 4, 2025 |
| Mar 1, 2025 | AGrant or award Common Stock10b5-1 | +53,975 | $0.00 | $0 | 84,662 | Mar 4, 2025 |
| Mar 1, 2025 | FTax withholding Common Stock10b5-1 | -26,097 | $8.33 | $217k | 58,565 | Mar 4, 2025 |
| Mar 3, 2025 | POpen-market purchase Common Stock10b5-1 | +11,709 | $8.56 | $100k | 70,274 | Mar 4, 2025 |
| Feb 28, 2025 | AGrant or award Restricted Stock Unitderivative10b5-1 | +90,036 | $0.00 | $0 | 90,036 | Mar 4, 2025 |
| Mar 1, 2025 | MOption exercise Restricted Stock Unitderivative10b5-1 | -28,333 | $0.00 | $0 | 56,667 | Mar 4, 2025 |
Related signals
Other insiders at Inogen Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | Inogen Inc | Michael J. Bourque EVP, CFO & Treasurer | $25k 3,000 shares | +7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.